Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van Boven

Showing results (141-150 of 217) with videos related to

Pageof 22
Sort By:
Plos One|January 12, 2016
Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the LiteratureElizabeth J J Berm, Margot de Looff, Bob Wilffert, et al.
Respiratory Medicine|September 28, 2013
Clinical and economic impact of non-adherence in COPD: a systematic reviewJob F M van Boven, Niels H Chavannes, Thys van der Molen, et al.
Respiratory Research|December 13, 2017
Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish populationLeif Bjermer, Job F M van Boven, Madlaina Costa-Scharplatz, et al.
BMJ Open|October 29, 2018
Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UKJaco Voorham, Nicolas Roche, Hicham Benhaddi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area valuesWalter J Loos, Felix E de Jongh, Alex Sparreboom, et al.
NPJ Primary Care Respiratory Medicine|May 31, 2022
Medication availability and economic barriers to adherence in asthma and COPD patients in low-resource settingsAizhamal Tabyshova, Talant Sooronbaev, Azamat Akylbekov, et al.
Journal of Thoracic Disease|July 19, 2021
Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalersEvalyne M Jansen, Susanne J van de Hei, Boudewijn J H Dierick, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|August 14, 2024
Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic reviewCarina M E Hansen, Anna J Breukelman, Patricia M L A van den Bemt, et al.
Expert Review of Respiratory Medicine|September 13, 2024
Overcoming challenges of managing chronic obstructive pulmonary disease in low- and middle-income countriesPatricia Alupo, Joseph Baluku, Felix Bongomin, et al.
Expert Opinion on Pharmacotherapy|August 5, 2024
Reshaping respiratory care: potential advances in inhaled pharmacotherapy in asthmaBoudewijn J H Dierick, Amber A Eikholt, Susanne J van de Hei, et al.
Pageof 22

Showing results (141-150 of 217) with videos related to

Sort By:
Pageof 22
Plos One|January 12, 2016
Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the LiteratureElizabeth J J Berm, Margot de Looff, Bob Wilffert, et al.
Respiratory Medicine|September 28, 2013
Clinical and economic impact of non-adherence in COPD: a systematic reviewJob F M van Boven, Niels H Chavannes, Thys van der Molen, et al.
Respiratory Research|December 13, 2017
Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish populationLeif Bjermer, Job F M van Boven, Madlaina Costa-Scharplatz, et al.
BMJ Open|October 29, 2018
Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UKJaco Voorham, Nicolas Roche, Hicham Benhaddi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area valuesWalter J Loos, Felix E de Jongh, Alex Sparreboom, et al.
NPJ Primary Care Respiratory Medicine|May 31, 2022
Medication availability and economic barriers to adherence in asthma and COPD patients in low-resource settingsAizhamal Tabyshova, Talant Sooronbaev, Azamat Akylbekov, et al.
Journal of Thoracic Disease|July 19, 2021
Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalersEvalyne M Jansen, Susanne J van de Hei, Boudewijn J H Dierick, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|August 14, 2024
Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic reviewCarina M E Hansen, Anna J Breukelman, Patricia M L A van den Bemt, et al.
Expert Review of Respiratory Medicine|September 13, 2024
Overcoming challenges of managing chronic obstructive pulmonary disease in low- and middle-income countriesPatricia Alupo, Joseph Baluku, Felix Bongomin, et al.
Expert Opinion on Pharmacotherapy|August 5, 2024
Reshaping respiratory care: potential advances in inhaled pharmacotherapy in asthmaBoudewijn J H Dierick, Amber A Eikholt, Susanne J van de Hei, et al.
Pageof 22